Longevity science
87.1K views | +0 today
Follow
Longevity science
Live longer in good health and you will have a chance to extend your healthy life even further
Your new post is loading...
Your new post is loading...
Scooped by Ray and Terry's
Scoop.it!

How EPA helps the heart

How EPA helps the heart | Longevity science | Scoop.it

How does fish oil protect the heart? The answer to this question has been elusive so far. Scientists know that omega-3 fatty acids exert an anti-inflammatory effect, but the mechanism had not been clearly followed.

 

A new study has now mapped the cellular process occurring after EPA supplementation and found that the nutrient blocks the cyclooxygenase enzyme (COX), which is a precursor to inflammation. COX produces hormones called prostaglandins, which cause inflammation in the body.

 

This is similar to the mechanism of aspirin, which blocks COX-2 signaling, thereby reducing inflammation and pain.

 

Ref: Norris PC, Dennis EA. “Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling.” Proc Natl Acad Sci U S A. 2012 May 14. [Epub ahead of print] PMID: 22586114

 

No comment yet.
Scooped by Ray and Terry's
Scoop.it!

Can an aspirin a day keep cancer away? – - CNN.com Blogs

Can an aspirin a day keep cancer away? – - CNN.com Blogs | Longevity science | Scoop.it

"Aspirin is recognized for its effects in heart-attack prevention. And several studies 'have provided evidence that nonsteroidal anti-inflammatory drugs (NSAIDs), including aspirin, may hold promise in helping to prevent cancer,'...

 

In particular, we show that aspirin reduces the likelihood that cancers will spread..."

No comment yet.
Scooped by Ray and Terry's
Scoop.it!

Aspirin tied to lower lung cancer risk in women

Aspirin tied to lower lung cancer risk in women | Longevity science | Scoop.it

NEW YORK (Reuters Health) - In a new study of more than 1,200 Asian women, those who took aspirin at least a couple of times a week had a much lower risk of developing lung cancer -- whether or not ...

No comment yet.